obesity patients, Novo Nordisk is fighting to maintain its position in what could be a $150 billion industry by 2035
[DOI] [PMC free article] [PubMed] [Google Scholar] 67.Tack J., Verbeure W., Mori H., Schol J., Van den Houte K., Huang I.H., Balsiger L., Broeders B., Colomier E., Scarpellini E., et al
The second difference is the delivery format opportunity
Each month, the patient is sent home with four injections to self-administer
HSS Journal (2025) 8
This article could not independently confirm the exact legal entity name of the specific credentialing medical group behind Zevay's program, since Telegra MD's own materials describe itself as a facilitating technology platform working through separate, unnamed "Provider Groups." Which pharmacy fills Zevay prescriptions